{"lastClose": 10.550000190734863, "len": 1223, "date": "2023-04-04", "alpha_1": 0.5747568634937672, "beta_1": 0.8291272464224572, "drawup_1": 1.2434209803960319, "sharpe_1": 0.25284589574484206, "natr_1": 6.380096659761731, "sup_1": -0.2360189615158824, "res_1": 0.03459716420954657, "bullPattern_1": [], "bearPattern_1": ["LONGLINE"], "rsi_1": 27.73723051163343, "adx_1": 40.37409483976825, "drawdown_1": -0.3812316326793159, "stratHoldSharpe_1": 0.2000444096361827, "stratHoldAlpha_1": 251.10492058351886, "stratHoldDrawdown_1": -0.3559259790410738, "alpha_3mo": -0.7619469636448845, "beta_3mo": 0.6203509426588046, "drawup_3mo": 0.054466229126168386, "natr_3mo": 6.380096659761731, "sup_3mo": -0.04802529005634704, "res_3mo": 0.1456555947340425, "bullPattern_3mo": [], "bearPattern_3mo": ["ENGULFING"], "rsi_3mo": 35.0515524732111, "adx_3mo": 49.84756958308278, "drawdown_3mo": -0.30728821353689073, "stratHoldSharpe_3mo": -3.598790588017977, "stratHoldAlpha_3mo": 249.83798916700187, "stratHoldDrawdown_3mo": -0.27778140995433365, "Name": "Kiniksa Pharmaceuticals Ltd. Class A", "Market Cap": 735895448, "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "IPO Year": 2018.0, "Country": "United States", "alpha%_1": 0.9729315701426472, "beta%_1": 0.37966626556836014, "drawup%_1": 0.9731005153737863, "sharpe%_1": 0.33266425757706214, "natr%_1": 0.8261635127835494, "drawdown%_1": 0.5005552335404181, "stratHoldSharpe%_1": 0.6402660977450522, "stratHoldAlpha%_1": 0.6884665139222955, "stratHoldDrawdown%_1": 0.4770416538947835, "alpha%_3mo": 0.13143521175915113, "beta%_3mo": 0.24171283440471975, "drawup%_3mo": 0.13586312601628264, "natr%_3mo": 0.8180547553788986, "drawdown%_3mo": 0.17218525970212561, "stratHoldSharpe%_3mo": 0.01530116923590707, "stratHoldAlpha%_3mo": 0.021485437146754546, "stratHoldDrawdown%_3mo": 0.17842081656792352}